Pulmonary resection for patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1687-1695

  Xu, Hong Bin ^a   Jiang, Rui Hua ^a   Li, Ling ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

MDR TB; Pulmonary surgical procedures; Treatment outcome

Indexed keywords

ARTICLE; COCHRANE LIBRARY; EMBASE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG LOBECTOMY; LUNG RESECTION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VALIDITY; WEDGE RESECTION;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LUNG; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 79960448247     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr210     Document Type: Article

References (58)

1. WHO. Global Tuberculosis Control 2009: Epidemiology, Strategy, Financing. WHO/HTM/TB/2009.411. http://www.who.int/entity/tb/publications/global_report/2009/pdf/full_report.pdf (1 March 2011, date last accessed).
2. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
3. Freixinet JG, Rivas JJ, Rodriguez de Castro F et al. Role of surgery in pulmonary tuberculosis. Med Sci Monitor 2002; 8: CR782-6.
4. Souilamas R, Riquet M, Barthers F et al. Surgical treatment of active and sequelar forms of pulmonary tuberculosis. Ann Thorac Surg 2001; 71: 443-7.
5. Picciocchi A, Granone P, Margaritora S et al. Surgical management of pulmonary tuberculosis. Rays 1998; 23: 193-202.
6. Treasure R, Seaworth B. Current role of surgery in Mycobacterium tuberculosis. Ann Thorac Surg 1995; 59: 1405-9.
7. Massard G, Dabagh A, Wihlm J et al. Pneumonectomy for chronic infection is a high-risk procedure. Ann Thorac Surg 1996; 62: 1033-8.
8. Pomerantz M, Mault J. History of resectional surgery for tuberculosis and other mycobacterial infections. Chest Surg Clin North Am 2000; 10: 131-3.
9. Perelman M, Strelzov V. Surgery for pulmonary tuberculosis. World J Surg 1997; 21: 457-67.
10. Lahiri T, Agrawal D, Gupta R et al. Analysis of status of surgery in thoracic tuberculosis. Indian J Chest Dis Allied Sci 1998; 40: 99-108.
11. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-91.
12. Nachega JB, Chaisson RE. Tuberculosis drug resistance: a global threat. Clin Infect Dis 2003; 36 (Suppl 11): S24-30.
13. Centers for Disease Control and Prevention. Revised definition of extensively drug-resistant tuberculosis. MMWR 2006; 55: 1176.
14. Wright A, Zignol M. Anti-tuberculosis Drug Resistance in the World: Fourth Global Report. Geneva: WHO, 2008.
15. Nathanson E, Gupta R, Huamani P et al. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis 2004; 8: 1382-4.
16. Tahaoglu K, Torun T, Sevim T et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001; 19: 170-4.
17. Iseman MD. Management of multidrug-resistant tuberculosis. Chemotherapy 1999; 45 (Suppl 2): 3-11.
18. Centers for Disease Control and Prevention. Extensively drug resistant tuberculosis-United States, 1993-2006. MMWR 2007; 56: 250-3.
19. Caminero JA. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829-37.
20. Leimane V, Riekstina V, Holtz TH et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005; 365: 318-26.
21. Nathanson E, Lambregts-van Weezenbeek C, Rich ML et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 2006; 12: 1389-97.
22. Suarez PG, Floyd K, Portocarrero J et al. Feasibility and cost-effectiveness of standardised secondline drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002; 359: 1980-9.
23. Mitnick C, Bayona J, Palacios E et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-28.
24. Palmero DJ, Ambroggi M, Brea A et al. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina. Int J Tuberc Lung Dis 2004; 8: 778-84.
25. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
26. Pomerantz BJ, Cleveland JC Jr, Olson HK et al. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001; 121: 448-53.
27. Park SK, Lee CM, Heu JP et al. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2002; 6: 143-9.
28. Chan ED, Laurel V, Strand MJ et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169: 1103-9.
29. Somocurcio JG, Sotomayor A, Shin S et al. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving communitybased treatment in Lima, Peru. Thorax 2007; 62: 416-21.
30. World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency Update 2008. WHO/HTM/TB/2008.402. Geneva: World Health Organization, 2008.
31. Blumberg HM, Burman WJ, Chaisson RE et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
32. Moher D, Cook DJ, Eastwood S et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-900.
33. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med 1995; 14: 2685-99.
34. Gelman A, Carlin JB, Stern HS et al. Bayesian Data Analysis. Boca Raton: CRC Press, 2003.
35. Brooks S, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998; 7: 434-55.
36. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-60.
37. Leuven MV, Groot MD, Shean KP et al. Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis. Ann Thorac Surg 1997; 63: 1368-73.
38. Sung SW, Kang CH, Kim YT et al. Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J Cardiothorac Surg 1999; 16: 187-93.
39. Chiang CY, Yu MC, Bai KJ et al. Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan. Int J Tuberc Lung Dis 2001; 5: 272-7.
40. Naidoo R, Reddi A. Lung resection for multidrug-resistant tuberculosis. Asian Cardiovasc Thorac Ann 2005; 13: 172-4.
41. Kwon YS, Kim YH, Suh GY et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008; 47: 496-502.
42. Park SK, Kim JH, Kang H et al. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Int J Infect Dis 2009; 13: 170-5.
43. Kir A, Inci I, Torun T et al. Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2006; 131: 693-6.
44. Mohsen T, Zeid AA, Haj-Yahia S. Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience. J Thorac Cardiovasc Surg 2007; 134: 194-8.
45. Wang HF, Lin HS, Jiang G. Pulmonary resection in the treatment of multidrug-resistant tuberculosis: a retrospective study of 56 cases. Ann Thorac Surg 2008; 86: 1640-5.
46. Shiraishi YJ, Katsuragi N, Kita H et al. Aggressive surgical treatment of multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2009; 138: 1180-4.
47. Kang MW, Kim HK, Choi YS et al. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010; 89: 1597-602.
48. Sharma SK, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 2006; 130: 162-272.
49. Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health. New Engl J Med 2007; 356: 656-9.
50. Mukherjee JS, Rich ML, Socci AR et al. Programmes and principles for management of multidrug-resistant tuberculosis. Lancet 2004; 372: 474-81.
51. Orenstein EW, Basu S, Sarita Shah N et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 153-61.
52. Johnston JC, Shahidi NC, Sadatsafavi M et al. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE 4: e6914.
53. Torun T, Tahaoglu K, Ozmen I et al. The role of surgery and fluoroquinolone in the treatment of multidrug resistant tuberculosis. Int J Tuberc Lung Dis 2007; 11: 979-85.
54. Lalloo UG, Naidoo R, Ambaram A. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Curr Opin Pulm Med 2006; 12: 179-85.
55. Wells CD, Cegielski JP, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 (Suppl 1): 86-107.
56. Laserson KF, Thorpe LE, Leimane V et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-5.
57. Tatsioni A, Zarin DA, Aronson N et al. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 2005; 142: 1048-55.
58. WHO. The Stop TB Strategy: Building on and Enhancing DOTS to Meet the TB-related Millennium Development Goals. Geneva: WHO, 2006.